XML 107 R91.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information - Financial Information by Segment (Detail)
$ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
segment
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Segment Reporting [Abstract]      
Number of reportable segments | segment 2    
Segment Reporting, Revenue Reconciling Item [Line Items]      
Net revenue $ 9,955,475 $ 9,785,315 $ 8,480,177
Operating earnings (loss) 142,913 368,473 204,118
Intangible amortization (78,800) (39,800) (41,500)
Acquisition-related and exit and realignment charges (55,022) (34,076) (37,752)
Inventory valuation adjustment (92,275) 0 0
Depreciation and amortization 228,667 90,621 93,336
Consolidated capital expenditures 166,582 49,690 59,193
Operating Segments      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Net revenue 9,955,475 9,785,315 8,480,177
Operating Segments | Products & Healthcare Services      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Net revenue 7,898,397 8,825,646 7,662,429
Operating earnings (loss) 175,309 384,390 215,698
Depreciation and amortization 77,539 75,548 77,131
Consolidated capital expenditures 49,824 48,282 55,110
Operating Segments | Patient Direct      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Net revenue 2,057,078 959,669 817,748
Operating earnings (loss) 193,748 57,966 67,662
Depreciation and amortization 151,128 15,073 16,205
Consolidated capital expenditures 116,758 1,408 1,056
Segment Reconciling Items      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Intangible amortization (78,847) (39,807) (41,490)
Acquisition-related and exit and realignment charges (55,022) (34,076) (37,752)
Discontinued operations $ 0 $ 0 $ 3,027